Clinical trials
Terminated Phase 3 Multiple Myeloma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2020 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 24 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Arkansas | 3 |
| Merck Sharp & Dohme LLC | 2 |
| Oncopeptides AB | 2 |
| AB Science | 1 |
| AEterna Zentaris | 1 |
| Case Comprehensive Cancer Center | 1 |
| Central Hospital, Nancy, France | 1 |
| European Society for Blood and Marrow Transplantation | 1 |
| Fondazione EMN Italy Onlus | 1 |
| GlaxoSmithKline | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 24 |
| Blast Crisis | 2 |
| Breast Neoplasms | 2 |
| Burkitt Lymphoma | 2 |
| Carcinoma, Ovarian Epithelial | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Leukemia, Myeloid, Accelerated Phase | 2 |
| Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 2 |
| Leukemia, Myeloid, Chronic-Phase | 2 |
| Leukemia, Myelomonocytic, Chronic | 2 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.